99 related articles for article (PubMed ID: 11212175)
1. The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue.
Goossens PH; Vogels R; Pieterman E; Havenga MJ; Bout A; Breedveld FC; Valerio D; Huizinga TW
Arthritis Rheum; 2001 Jan; 44(1):48-52. PubMed ID: 11212175
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
Sakurai F; Mizuguchi H; Hayakawa T
Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
[TBL] [Abstract][Full Text] [Related]
3. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.
Yamamoto A; Fukuda A; Seto H; Miyazaki T; Kadono Y; Sawada Y; Nakamura I; Katagiri H; Asano T; Tanaka Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2003 Sep; 48(9):2682-92. PubMed ID: 13130489
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.
Toh ML; Hong SS; van de Loo F; Franqueville L; Lindholm L; van den Berg W; Boulanger P; Miossec P
J Immunol; 2005 Dec; 175(11):7687-98. PubMed ID: 16301679
[TBL] [Abstract][Full Text] [Related]
5. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
Terzioglu E; Bisgin A; Sanlioglu AD; Ulker M; Yazisiz V; Tuzuner S; Sanlioglu S
Rheumatology (Oxford); 2007 May; 46(5):783-9. PubMed ID: 17309888
[TBL] [Abstract][Full Text] [Related]
6. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.
van der Laan WH; Quax PH; Seemayer CA; Huisman LG; Pieterman EJ; Grimbergen JM; Verheijen JH; Breedveld FC; Gay RE; Gay S; Huizinga TW; Pap T
Gene Ther; 2003 Feb; 10(3):234-42. PubMed ID: 12571631
[TBL] [Abstract][Full Text] [Related]
7. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP
Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906
[TBL] [Abstract][Full Text] [Related]
8. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype.
Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N
Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727
[TBL] [Abstract][Full Text] [Related]
9. The effect of apoptosis signal-regulating kinase 1 gene transfer on rat collagen induced arthritis.
Terauchi R; Arai Y; Takahashi KA; Inoue A; Tonomura H; Asada H; Kishida T; Imanishi J; Mazda O; Kitajima I; Kubo T
J Rheumatol; 2005 Dec; 32(12):2373-80. PubMed ID: 16331767
[TBL] [Abstract][Full Text] [Related]
10. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
[TBL] [Abstract][Full Text] [Related]
11. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
Neumann E; Judex M; Kullmann F; Grifka J; Robbins PD; Pap T; Gay RE; Evans CH; Gay S; Schölmerich J; Müller-Ladner U
Gene Ther; 2002 Nov; 9(22):1508-19. PubMed ID: 12407423
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid.
Bastian A; Bewig B
Gene Ther; 1999 Apr; 6(4):637-42. PubMed ID: 10476223
[TBL] [Abstract][Full Text] [Related]
15. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.
Castagnetta LA; Carruba G; Granata OM; Stefano R; Miele M; Schmidt M; Cutolo M; Straub RH
J Rheumatol; 2003 Dec; 30(12):2597-605. PubMed ID: 14719200
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
[TBL] [Abstract][Full Text] [Related]
17. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ
Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
19. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
[TBL] [Abstract][Full Text] [Related]
20. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
